Dan Oren's Net Worth
$980 Million
Who is Dan Oren?
Dan Oren has an estimated net worth of $980 Million. This is based on reported shares across multiple companies, which include Roivant Sciences Ltd., Arbutus Biopharma Corp, Myovant Sciences Ltd., Urovant Sciences Ltd., Axovant Gene Therapies Ltd., Intec Pharma Ltd., and Protalix BioTherapeutics, Inc..
SEC CIK
Dan Oren's CIK is 0001636701
Past Insider Trading and Trends
2019 was Dan Oren's most active year for acquiring shares with 28 total transactions. Dan Oren's most active month to acquire stocks was the month of May. 2020 was Dan Oren's most active year for disposing of shares, totalling 3 transactions. Dan Oren's most active month to dispose stocks was the month of January. 2018 saw Dan Oren paying a total of $161,399,997.55 for 28,738,300 shares, this is the most they've acquired in one year. In 2021 Dan Oren cashed out on 918,717 shares for a total of $2,088,857.27, their largest year based on trade value.
Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!
Roivant Sciences Ltd. (ROIV) Snapshot price: $10.39
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
| +4.05% | 4M |
$5.00 | $20,000,000.00 | 102.85M |
Nov 10
| |||
Form 4
| +0.04% | 40.28K |
$3.85 | $154,954.16 | 98.85M |
Apr 22 - Apr 25
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
Arbutus Biopharma Corp (ABUS) Snapshot price: $2.47
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
|
—
|
0
|
—
|
—
|
0
| ||||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jan 12
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Oct 16
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
Myovant Sciences Ltd. No price found
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
|
—
|
0
|
—
|
—
|
0
| ||||
Form 4
| +6.32% | 2.42M |
$8.25 | $19,999,996.50 | 40.77M |
Jun 4
| |||
Form 4
| +2.98% | 1.11M |
$20.27 | $22,500,004.05 | 38.34M |
Apr 2
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
Urovant Sciences Ltd. No price found
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
|
—
|
0
|
—
|
—
|
0
| ||||
Form 4
| +0.04% | 18.2K |
$8.36 | $151,380.99 | 45.71M |
Scheduled
|
Jun 17 - Jun 19
| ||
Form 4
| +0.05% | 22.01K |
$8.12 | $177,300.64 | 45.67M |
Scheduled
|
Jun 12 - Jun 14
| ||
Form 4
| +0.05% | 21.34K |
$8.22 | $177,247.38 | 45.62M |
Scheduled
|
Jun 7 - Jun 11
| ||
Form 4
| +0.05% | 21.12K |
$7.80 | $165,950.15 | 45.58M |
Scheduled
|
Jun 4 - Jun 6
| ||
Form 4
| +0.04% | 17.75K |
$7.86 | $138,946.36 | 45.54M |
Scheduled
|
May 30 - Jun 3
| ||
Form 4
| +0.03% | 14.48K |
$7.65 | $110,461.18 | 45.51M |
Scheduled
|
May 24 - May 29
| ||
Form 4
| +0.02% | 9.84K |
$7.91 | $77,809.93 | 45.49M |
Scheduled
|
May 22 - May 23
| ||
Form 4
| +0.04% | 9.99K |
$8.52 | $85,108.42 | 22.74M |
May 21
| |||
Form 4
| +0.02% | 10K |
$8.19 | $80,524.83 | 45.45M |
May 20
| |||
Form 4
| +0.03% | 11.61K |
$7.08 | $82,359.46 | 45.42M |
May 16 - May 17
| |||
Form 4
| +13.38% | 2.68M |
$14.00 | $37,499,994.00 | 22.7M |
Oct 1
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
Axovant Gene Therapies Ltd. (SIOX) Snapshot price: $0.475
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
|
—
|
0
|
—
|
—
|
0
| ||||
Form 4
| +6.71% | 6.67M |
$1.50 | $10,000,000.50 | 105.95M |
Mar 18
| |||
Form 4
| +11.20% | 10M |
$1.00 | $10,000,000.00 | 99.29M |
Dec 18
| |||
Form 4
| +19.05% | 14.29M |
$1.75 | $24,999,999.50 | 89.29M |
Jun 5
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||